Literature DB >> 24065759

eComment. Consider trying levosimendan.

Nicholas A Desimonas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24065759      PMCID： PMC3781825          DOI： 10.1093/icvts/ivt367

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN： 1569-9285


× No keyword cloud information.
  5 in total

1.  Can pulmonary artery hypertension be attributed to levosimendan? A problematic based on a patient's case.

Authors:  Georgios I Tagarakis; Andony J Baddour; Nikolaos B Tsilimingas
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2010-07       Impact factor: 2.160

Review 2.  Is levosimendan effective in paediatric heart failure and post-cardiac surgeries?

Authors:  Ullas Angadi; Claire Westrope; Mohammed F Chowdhry
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07-06

Review 3.  Levosimendan for heart-operated patients: what is the state of the art?

Authors:  Georgios I Tagarakis; Nikolaos B Tsilimingas
Journal:  Recent Pat Cardiovasc Drug Discov       Date:  2009-01

Review 4.  Pharmacology of levosimendan: inotropic, vasodilatory and cardioprotective effects.

Authors:  A Pathak; M Lebrin; A Vaccaro; J M Senard; F Despas
Journal:  J Clin Pharm Ther       Date:  2013-04-18       Impact factor: 2.512

5.  The costs of treating acute heart failure: an economic analysis of the SURVIVE trial.

Authors:  Gregory de Lissovoy; Kathy Fraeman; Jeff Salon; Tatia Chay Woodward; Raimund Sterz
Journal:  J Med Econ       Date:  2008       Impact factor: 2.448
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.